Key Highlights

  • Surrozen (NASDAQ:SRZN) rose 11.2% to 27.97 on October 8, 2026, appearing on an exchange gainers scoreboard that also listed Pacira, Fly-E, Jianzhi Education, Xiao-I and Haemonetics.
  • Pacira BioSciences (NASDAQ:PCRX) led the healthcare names with a gain of about 44%, according to exchange market data for the session, with Haemonetics up 17.5%.
  • Fly-E gained about 83%, Jianzhi Education 77% and Xiao-I 46%, extreme moves in small caps whose catalysts the topics file lists as unknown, so no reasons are asserted here.
  • A gainers scoreboard ranks price moves only, so Surrozen (NASDAQ:SRZN) and its peers can appear after thin trading, headlines or short squeezes that the list itself does not explain.

The Gainers Scoreboard

Exchange market data for October 8, 2026 showed a group of large gainers. Pacira rose about 44%, Fly-E 83%, Jianzhi Education 77%, Xiao-I 46% and Haemonetics 17.5%. Surrozen (NASDAQ:SRZN) climbed 11.2% to 27.97 and was grouped with them, alongside a 16.4% move in Cable One whose direction conflicts across reports. The topics file marks the catalysts for most small caps as unknown, which is the critical caveat: a ranking by price move shows where trading happened, not why. Each figure is a snapshot of one session and should be rechecked against the close. Cable One is a separate case, as one market print shows it up and another recap says it fell, so it is not treated as a verified gainer.

How to Read a Gainers List

A top-gainers list sorts stocks by one-day price change, so it favors small, thinly traded shares where a few orders can move the price. Large gains can follow clinical data, financing news, Takeover talk, index changes or purely technical squeezes, and a scoreboard cannot tell them apart. Pacira BioSciences (NASDAQ:PCRX) is an established healthcare company, as is Haemonetics, so their moves may reflect company or sector news, but the file does not name it. Surrozen (NASDAQ:SRZN) is a smaller biotech name, and an 11.2% gain to 27.97 needs a filing or release before any explanation can be trusted. Traders also use such lists to find momentum, but momentum without news is fragile, and Liquidity can vanish quickly when the buying stops.

Risks and What to Watch

The risk with chasing gainers is that the move reverses the next day, especially for names with no confirmed catalyst. Investors should check each company for an 8-K, a press release or a trial update, and should compare the move with a benchmark. The Nasdaq Composite fell 1.25% on the day, so strength in these names stood out against a weak tape. Upcoming macro dates include September CPI on October 14, 2026 and the Federal Reserve meeting on October 27 and 28, 2026, both of which can shift risk appetite quickly. Surrozen (NASDAQ:SRZN) should be monitored for confirmed news, not assumed to be a trend.

Where Things Stand

The scoreboard shows who moved, not why. Surrozen (NASDAQ:SRZN) rose 11.2% to 27.97 alongside far bigger gains in Pacira, Fly-E, Jianzhi Education, Xiao-I and Haemonetics, but most catalysts are unknown. Treat the list as a map of where trading was heavy, and confirm each story with a filing before acting. The practical takeaway is to treat each name on the list as a lead for research, not a conclusion, and to wait for filings or releases before drawing any link between the moves.